MA02.06 a Randomized, Double-Blind, Placebo-Controlled Trial of Chemotherapy Combined With Yangzheng Xiaoji in Advanced NSCLC

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.326